2019
DOI: 10.1016/j.ejmech.2018.11.025
|View full text |Cite
|
Sign up to set email alerts
|

Benzofuran derivatives and their anti-tubercular, anti-bacterial activities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
47
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 125 publications
(49 citation statements)
references
References 85 publications
1
47
0
1
Order By: Relevance
“…Heterocyclic compounds in particular oxygen containing heterocycles represent an important class of compounds possessing interesting pharmacological and biological activities [21][22][23] . Benzofuran nucleus, as a key functional scaffold, represents a basic structure in a diversity of biologically active synthetic and natural products [24][25][26] , with broad range of desirable activities including; anti-Alzheimer's 27 , antibacterial 28 , anti-tubercular 29 , antioxidant 30 , anti-inflammatory 31 , as well as antitumor activities 32 . Benzofuran derivatives exert their antiproliferative activity with diversified mechanisms such as inhibition of tubulin polymerisation 33,34 , HIF-1 35 , Aurora B kinase 36 and VEGFR-2 activity 37 .…”
Section: Introductionmentioning
confidence: 99%
“…Heterocyclic compounds in particular oxygen containing heterocycles represent an important class of compounds possessing interesting pharmacological and biological activities [21][22][23] . Benzofuran nucleus, as a key functional scaffold, represents a basic structure in a diversity of biologically active synthetic and natural products [24][25][26] , with broad range of desirable activities including; anti-Alzheimer's 27 , antibacterial 28 , anti-tubercular 29 , antioxidant 30 , anti-inflammatory 31 , as well as antitumor activities 32 . Benzofuran derivatives exert their antiproliferative activity with diversified mechanisms such as inhibition of tubulin polymerisation 33,34 , HIF-1 35 , Aurora B kinase 36 and VEGFR-2 activity 37 .…”
Section: Introductionmentioning
confidence: 99%
“…Lung infections, headed by tuberculosis have been implicated as potentially contributing to lung cancer 35 . In this study, we decided to explore the potential anti-tubercular activity of target benzofuran derivatives 17 . The three most promising benzofuran-based derivatives herein reported (4b, 15a and 16a) were assessed for their potential anti-tubercular activity towards M. tuberculosis following the procedures of the Microplate Alamar Blue Assay 36 , and using INH as a reference anti-TB drug.…”
Section: Anti-tubercular Activitymentioning
confidence: 99%
“…Benzofuran derivatives tagged with diverse pharmacophoric groups proved to possess multiple pharmacological activities for the past decades 9,10 . Among these pharmacological activities, benzofuran derivatives exhibit significant inhibitory carbonic anhydrase 11,12 , antioxidant 13 , anti-Alzheimer's 14 , anti-inflammatory 15 , antibacterial 15,16 , antitubercular 17 , as well as anticancer activities 18 . Benzofurans were reported to exert their antiproliferative activities through diverse mechanisms of cellular proliferation inhibition including apoptosis induction [19][20][21][22][23] and VEGFR-2 inhibitory action [24][25][26] .…”
Section: Introductionmentioning
confidence: 99%
“…For example, (+)-liphagal is a selective phosphoinositide-3-kinase -inhibitor (Marion et al, 2006), cyclopenta [b]benzofuran compounds possess antitumour and antiviral activities (Kim et al, 2006), while derivatives of egonol have antioxidant and anti-inflammatory activities (Timmers et al, 2015). Synthetic benzofuran derivatives are found to possess antitumour and anticancer (Shi et al, 2016;Marquès et al, 2016;Napió rkowska et al, 2019;Asadi et al, 2017), antimicrobial (Asadi et al, 2017;He et al, 2017;Xu et al, 2019) and antitubercular (Xu et al, 2019) activities. Some synthetic benzofuran derivatives have been investigated in the role of osteogenic (Marquè s et al, 2016;Kushwaha et al, 2018;Modukuri et al, 2017) or vasorelaxant (Hassan et al, 2014) agents.…”
Section: Introductionmentioning
confidence: 99%